Cargando…
Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea
INTRODUCTION: The persistent erythema and flushing seen in some cases of rosacea do not respond effectively to, or may easily relapse after, oral medication or light-based therapies (laser or intense pulsed light). Intradermal botulinum toxin A (BTX-A) injection can be used to treat intractable eryt...
Autores principales: | Yang, Rongli, Liu, Chang, Liu, Wenli, Luo, Jintian, Cheng, Shaoli, Mu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515256/ https://www.ncbi.nlm.nih.gov/pubmed/35925473 http://dx.doi.org/10.1007/s13555-022-00784-0 |
Ejemplares similares
-
Correction to: Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea
por: Yang, Rongli, et al.
Publicado: (2022) -
Light-Based Devices for the Treatment of Facial Erythema and Telangiectasia
por: Yepuri, Vani, et al.
Publicado: (2021) -
Botulin Toxin Use in Rosacea and Facial Flushing Treatment
por: Scala, Jacopo, et al.
Publicado: (2019) -
The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea
por: Johnson, Andrew William, et al.
Publicado: (2015) -
Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey
por: Dirschka, Thomas, et al.
Publicado: (2015)